Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toripalimab with Docetaxel and Cisplatin in Hypopharyngeal Cancer
NCT04296747Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Mar 2020
- Primary completion
- Mar 2022
01
Overview
A Phase 2 trial of toripalimab in hypopharyngeal squamous cell carcinoma (HSCC), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
toripalimab
03
Conditions
hypopharyngeal squamous cell carcinoma (HSCC)
Beyond the preview
Go deeper on NCT04296747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04296747.